The Icahn Genomics Institute (IGI) at the Icahn School of Medicine at Mount Sinai in New York City invites applications for tenure-track faculty positions at the Assistant, Associate, or Full Professor levels in RNA and CRISPR therapeutics, gene and cell therapy, and nanoparticle medicine.

We are inviting applications for tenure-track faculty position (Assistant, Associate, Full Professor level) for scientists that are working to develop the next generation of RNA and DNA-based therapies and vaccines. This includes bioengineers and biochemists working on the fundamental technologies that power these therapies, especially those working on the development of new nucleic acid delivery technologies, such as lipid nanoparticles (LNP) and viral vectors, novel CRISPR gene and base editing tools, mRNA formulations and oligonucleotide therapeutics, chimeric antigen receptors (CAR), and approaches for more sophisticated control of transgene expression. We are also looking for scientists and clinicians applying DNA and RNA technologies and gene engineering to the treatment of disease, including cancer, inflammatory disease, monogenic disorders, and infectious disease.

The Icahn Genomics Institute is a hub of gene therapy science and clinical practice, with a bench to bedside track record in RNA and DNA therapies, including one of the first approved RNAi drugs. The candidate will joinan outstanding team of scientists with world class expertise in a broad range of disciplines, such as gene and cell therapy, genetics and genomics, immunology, cancer, cardiovascular biology, microbiotics, and infectious disease. The IGI philosophy is highly geared towards collaboration, inclusion, and cross-disciplinary interactions, particularly between basic scientists and clinicians, and we provide strong support to junior scientists.

Learn more about the Icahn Genomics Institute here.